SE7712430L - ANTIBIOTICS A 10 - Google Patents

ANTIBIOTICS A 10

Info

Publication number
SE7712430L
SE7712430L SE7712430A SE7712430A SE7712430L SE 7712430 L SE7712430 L SE 7712430L SE 7712430 A SE7712430 A SE 7712430A SE 7712430 A SE7712430 A SE 7712430A SE 7712430 L SE7712430 L SE 7712430L
Authority
SE
Sweden
Prior art keywords
gram
antibiotic
novel
lactamases
feedstuffs
Prior art date
Application number
SE7712430A
Other languages
Swedish (sv)
Other versions
SE433621B (en
Inventor
P J Cassidy
S B Zimmerman
J B Tunac
S Hernandez
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7712430L publication Critical patent/SE7712430L/en
Publication of SE433621B publication Critical patent/SE433621B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The novel compound of the formula <IMAGE> and its pharmaceutically acceptable salts are prepared by culture of an appropriate strain of Streptomyces flavogriseus in aqueous nutrient medium which contains assimilable sources of carbon, nitrogen and inorganic salts, under submerged, aerobic conditions and isolation of the antibiotic formed. The novel antibiotic is active against various Gram-positive and Gram-negative bacteria and is a potent inhibitor of bacterial ss-lactamases. It can be used in human and veterinary medicine and is also suitable as an additive to animal feed owing to preservation of feedstuffs and foodstuffs and as a disinfectant.
SE7712430A 1976-11-17 1977-11-03 SET TO MAKE ANTIBIOTICS 890 A? 7110 BY CULTIVATING STREPTOMYCES FLAVOGRISEUS SE433621B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74295876A 1976-11-17 1976-11-17

Publications (2)

Publication Number Publication Date
SE7712430L true SE7712430L (en) 1978-05-18
SE433621B SE433621B (en) 1984-06-04

Family

ID=24986929

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7712430A SE433621B (en) 1976-11-17 1977-11-03 SET TO MAKE ANTIBIOTICS 890 A? 7110 BY CULTIVATING STREPTOMYCES FLAVOGRISEUS

Country Status (10)

Country Link
JP (1) JPS5363397A (en)
CH (1) CH634104A5 (en)
DE (1) DE2751303A1 (en)
DK (1) DK487977A (en)
ES (1) ES463973A1 (en)
FR (1) FR2371448A1 (en)
GB (1) GB1595233A (en)
NL (1) NL7712092A (en)
PT (1) PT67268B (en)
SE (1) SE433621B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ190994A (en) 1978-07-24 1981-10-19 Merck & Co Inc Z-2-acylamino-3-monosubstituted propenoates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1483142A (en) * 1975-03-15 1977-08-17 Beecham Group Ltd Streptomycetal antibiotic
CH633554A5 (en) * 1975-11-21 1982-12-15 Merck & Co Inc Process for the preparation of novel thienamycin derivatives.

Also Published As

Publication number Publication date
FR2371448B1 (en) 1980-03-14
ES463973A1 (en) 1978-11-16
CH634104A5 (en) 1983-01-14
DK487977A (en) 1978-05-18
PT67268A (en) 1977-12-01
FR2371448A1 (en) 1978-06-16
PT67268B (en) 1979-10-08
DE2751303A1 (en) 1978-05-18
SE433621B (en) 1984-06-04
NL7712092A (en) 1978-05-19
JPS6310998B2 (en) 1988-03-10
GB1595233A (en) 1981-08-12
JPS5363397A (en) 1978-06-06

Similar Documents

Publication Publication Date Title
KR880004097A (en) Glycopeptide Antibiotics
MY102919A (en) Pleuromutilin derivatives process for their preparation and their use.
SE7704301L (en) ANTIBIOTICS
EP0196628A3 (en) Ansamycin antibioticum, microbiological process for its preparation and its use as a medicament
SE7712429L (en) ANTIBIOTICS 890 A9
SE7712430L (en) ANTIBIOTICS A 10
ES8308360A1 (en) A new polycyclic ether antibiotic.
SE7612293L (en) ANTIBIOTIC
ES8101544A1 (en) Urethane derivative
SE7707552L (en) ANTIBIOTICS BL580DELTA
SE7612295L (en) ANTIBIOTIC
SE7612294L (en) ANTIBIOTIC
SE7705855L (en) PROCEDURE FOR PREPARING A NEW ANTIBIOTIC CALLED A-35512
AU584946B2 (en) Organic chemical compound, microbiological processes for its preparation, and its use
IE41378L (en) Polycyclic ether antibiotic.
FR2401162A1 (en) ANTIBIOTIC DERIVED FROM A STREPTOMYCE, USED AS A MEDICINAL PRODUCT
SE7708939L (en) ANTIBIOTICS
FR2380277A1 (en) Antibacterial beta-lactam antibiotic - desacetyl-di:hydro-890A9 prepd. by enzymatic de:acetylation of di:hydro-890A9 and used e.g. as pharmaceutical or feed additive (NL 15.8.78)
SE8303727L (en) cephalosporin antibiotics
GB1388460A (en) N-demethyl-celesticetin derivatives
IL70952A (en) 19-epi-dianemycin and salts thereof,their preparation,pharmaceutical compositions and nutrient feed containing them
JPS562980A (en) Novel antibiotic substance a73a and its preparation
SE7412590L (en)
GEP19971048B (en) Method for preparation of antibiotic s541 and streptomycetes strains-producers of antibiotic s541
JPS5576874A (en) Novel antibiotic a40a and its preparation

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7712430-3

Effective date: 19900706

Format of ref document f/p: F